Skip to main content
Clinical Trials/NCT02020382
NCT02020382CompletedNot Applicable

Evaluation of the Diagnostic Value of microRNAs for Inflammatory Bowel Disease

Assistance Publique - Hôpitaux de Paris10 sites in 1 country325 target enrollmentStarted: December 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
325
Locations
10
Primary Endpoint
Evaluate the diagnostic value of microRNAs in qPCR,in IBD colon (ulcerative colitis or Crohn's disease) in adults compared to health

Study Overview

Brief Summary

The purpose of this study is to assess the diagnostic value of microRNAs in IBD colon (ulcerative colitis or Crohn's disease) in adults as compared to healthy controls (and non-IBD colitis)

Detailed Description

RATIONAL Inflammatory Bowel Disease (IBD) affects more than 200,000 people in France and 1.5 million in Europe. Difficulties in the management of IBD are related to the need for invasive tests for the diagnosis of IBD (endoscopy), partly explaining the delay in diagnosis, and the inability to distinguish early colonic Crohn's disease of ulcerative colitis (UC) in 10-30% of cases.

Recently, we identified real-time polymerase chain reaction (PCR), from healthy colonic mucosa of IBD patients, a molecular signature of IBD involving 10 microRNA (miRNA) Common (miR26a, miR29a, miR29b, miR126 * miR15a, miR127-3p, miR324 -3p, miR30c, miR185, miR196a) and 15 colic chronic disease (MC) and ulcerative colitis (RCH) discriminating microRNA (miR-142-3p, miR-142-5p, miR-146a, miR-146b-5p, miR150, miR-181d, miR-182, miR199a -3p, miR199a-5p, miR199b-5p, miR-203, miR223, miR-299-5p, miR320a, miR-328).

TYPE OF STUDY : multicenter diagnostic evaluation Study

MAIN PURPOSE OF THE STUDY : To evaluate the diagnostic value of microRNA in colonic IBD (ulcerative colitis or Crohn's disease) in adults as compared to healthy controls (and non-IBD colitis)

SECONDARY OBJECTIVES :

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
5 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • No health insurance ,
  • mental disability,
  • pregnancy

Arms & Interventions

Witnesses healthy children

Other

testing qPCR diagnostic KIT of microRNAS from colonic biopsies

Intervention: qPCR diagnostic KIT of microRNAS (Device)

Crohn adult colic

Other

testing qPCR diagnostic KIT of microRNAS from colonic biopsies

Intervention: qPCR diagnostic KIT of microRNAS (Device)

RCH adults

Other

testing qPCR diagnostic KIT of microRNAS from colonic biopsies

Intervention: qPCR diagnostic KIT of microRNAS (Device)

Witnesses healthy adults

Other

testing qPCR diagnostic KIT of microRNAS from colonic biopsies

Intervention: qPCR diagnostic KIT of microRNAS (Device)

Witnesses adults with non-IBD inflammation

Other

testing qPCR diagnostic KIT of microRNAS from colonic biopsies

Intervention: qPCR diagnostic KIT of microRNAS (Device)

Children with colitis

Other

testing qPCR diagnostic KIT of microRNAS from colonic biopsies

Intervention: qPCR diagnostic KIT of microRNAS (Device)

Outcomes

Primary Outcomes

Evaluate the diagnostic value of microRNAs in qPCR,in IBD colon (ulcerative colitis or Crohn's disease) in adults compared to health

Time Frame: 1 day

Evaluate the diagnostic value of microRNAs in qPCR, suitable for routine use, initially testing the expression of 25 miRNAs from endoscopic biopsies in IBD colon (ulcerative colitis or Crohn's disease) in adults compared to health

Secondary Outcomes

  • - Evaluate the ability of miRNAs to discriminate a MC colic of UC in adults(1 day)
  • Evaluate the diagnostic value of microRNAs in inflammatory colitis child(1 day)
  • - Study the possibility of measuring miRNA of interest in feces and saliva(1 day)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (10)

Loading locations...

Similar Trials

Evaluation of the Diagnostic Value of... | Clinical Trial